- NZ$771.65m
- NZ$3.10bn
- NZ$221.98m
- 45
- 90
- 61
- 70
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 8.69 | ||
| PEG Ratio (f) | 2.65 | ||
| EPS Growth (f) | 3.39% | ||
| Dividend Yield (f) | 3.58% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.52 | ||
| Price to Tang. Book | 0.53 | ||
| Price to Free Cashflow | 7.07 | ||
| Price to Sales | 3.28 | ||
| EV to EBITDA | 93.69 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 2.18% | ||
| Return on Equity | 5.76% | ||
| Operating Margin | 35.26% | ||
Financial Summary
| Year End 31st Mar | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | NZ$m | 152.44 | 163.65 | 174.45 | 201.66 | 221.98 | 277.44 | 293.59 | 10.91% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -9.36 | -23.77 | +128.87 | +38.87 | -72.76 | +27.84 | +3.39 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Arvida Group Limited is a New Zealand-based aged care provider. The Company is engaged in the business of owning, operating and developing retirement villages and care facilities for the elderly in New Zealand. The Company owns and operates 36 retirement villages located nationally with over 6,750 residents. Each village operates independently under a corporate structure that supports village operations to ensure quality and consistency of service. It provides a continuum of care that extends from independent living to full rest home, hospital and dementia-level care. It has 35 communities nationwide, many of which have gardens, workshops and a range of recreational facilities, in addition to providing a range of living options, from fully independent villas to full-time care. It has approximately 763 hospitals, 545 rest homes and 236 dementia care. It also has approximately 4126 total retirement units, out of which 3,208 villas/apartments, 706 serviced apartments and 212 care suites.
Directors
- Anthony Beverley CHM
- Jeremy Mark Nicoll CEO
- Mark Wells CFO
- Richard Davis COO
- Jonathan Ash GMG
- Kay Marshall GMG
- Tristan Saunders GMG
- Maria Scott-Multani GMG
- Teresa Seux GMG
- Susan Peterson IND
- Michael Ambrose NID
- Susan Paterson NID
- Paul Ridley-Smith NID
- Last Annual
- March 31st, 2023
- Last Interim
- September 30th, 2023
- Incorporated
- January 17th, 2014
- Public Since
- December 18th, 2014
- No. of Shareholders
- 7,364
- No. of Employees
- 2,917
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
New Zealand Stock Exchange- Shares in Issue
- 727,976,000
- Address
- Level 15, AUCKLAND, 1010
- Web
- https://www.arvida.co.nz/
- Phone
- +64 99721180
- Auditors
- Ernst & Young
Latest News for ARV
Upcoming Events for ARV
Full Year 2024 Arvida Group Ltd Earnings Release
Arvida Group Ltd Annual Shareholders Meeting
Similar to ARV
Greenfern Industries
New Zealand Stock Exchange
Oceania Healthcare
New Zealand Stock Exchange
Promisia Healthcare
New Zealand Stock Exchange
Radius Residential Care
New Zealand Stock Exchange
Ryman Healthcare
New Zealand Stock Exchange
FAQ
As of Today at 19:02 UTC, shares in Arvida are trading at NZ$1.06. This share price information is delayed by 15 minutes.
Shares in Arvida last closed at NZ$1.06 and the price had moved by +2.91% over the past 365 days. In terms of relative price strength the Arvida share price has underperformed the ASX All Ordinaries Index by -1.56% over the past year.
The overall consensus recommendation for Arvida is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Arvida does not currently pay a dividend.
Arvida does not currently pay a dividend.
Arvida does not currently pay a dividend.
To buy shares in Arvida you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of NZ$1.06, shares in Arvida had a market capitalisation of NZ$771.65m.
Here are the trading details for Arvida:
- Country of listing: New Zealand
- Exchange: NZC
- Ticker Symbol: ARV
Based on an overall assessment of its quality, value and momentum Arvida is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Arvida is NZ$1.38. That is 30% above the last closing price of NZ$1.06.
Analysts covering Arvida currently have a consensus Earnings Per Share (EPS) forecast of NZ$0.12 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Arvida. Over the past six months, its share price has underperformed the ASX All Ordinaries Index by -22.67%.
As of the last closing price of NZ$1.06, shares in Arvida were trading -6.85% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Arvida PE ratio based on its reported earnings over the past 12 months is 8.69. The shares last closed at NZ$1.06.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Arvida's management team is headed by:
- Anthony Beverley - CHM
- Jeremy Mark Nicoll - CEO
- Mark Wells - CFO
- Richard Davis - COO
- Jonathan Ash - GMG
- Kay Marshall - GMG
- Tristan Saunders - GMG
- Maria Scott-Multani - GMG
- Teresa Seux - GMG
- Susan Peterson - IND
- Michael Ambrose - NID
- Susan Paterson - NID
- Paul Ridley-Smith - NID